Contova®

Olopatadine
Contova®

Prescribing Details



Description

Contova ® is a preparation of Olopatadine which has anti-allergic properties. lt is a relatively selective H1 -receptor anatagonist and inhibitor of histamine release from the mast cell.


Uses

No Data


Indications

Contova ® 0.1% eye drops is indicated for the signs and symptoms of allergic conjunctivitis.


Dosage and administration

The recommended dose is one drop in each affected eye two times per day at an interval of 6 to 8 hours.Safety and effectiveness of Olopatadine in paediatric patients below the age of 3 years have not been established.


Use in pregnancy & lactation

No adequate and well controlled studies in pregnant women have been performed. Therefore, it should be carefully considered whether potential benefit to the mother justifies the potential risk to the embryo or fetus.lt is not known whether topical ocular administraiion could result in sufficient systemic absorption to produce detectable quantities in human breast milk. Olopatadine eye drops should be used with caution in breastfeeding woman.


Geriatric use
No Data

Precautions

Patients should be advised not to wear contact lens if the eye is red.lt should not be used to treat contact lens related irritation.

Warnings
lnstillation of eye drops may cause transient blurring of vision.Caution should be taken when driving or operating machinery if blurred vision is experienced.


Side effects
The common side-effects are headache, asthenia,blurred vision, burning or stinging,cold syndrome, dry eye, foreign body sensation, hyperaemia,hypersensitivity, keratitis, lid edema, nausea,pharyngitis, pruritus, rhinitis, sinusitis and taste perversion.

Contraindications

Olopatadine eye drops are contraindicated in patients hypersensitive to Olopatadine hydrochloride or any other component of the preparation.


Drug interactions

Contova ® eye drops has low drug interaction potential as systemic levels of Olopatadine achieved after ocular dosing are negligible.


Overdose
No specific ocular side effects are known for a topical overdosage of Olopatadine eye drops.
A topical overdosage of Olopatadine eye drops may be flushed from the eye(s) with warm tap water.
Contova ® eye drops is safe up to a dose of 360mg systemically (one bottle of Olopatadine eye drops contains 5mg)

Preparation

No Data


Pharmaceutical precautions

Store in a cool & dry place.Protect from light.
Discard container 1 month after opening.


Presentation

Each ml contains Olopatadine 1 mg as Hydrochloride INN


Package quantitie
Contova ® eye drops: Plastic dropper bottle of 5ml.
Contova® Prescribing Information